Ursprung des Netzwerks ersten Grades von Greg Martini
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 41 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Greg Martini
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member President Investor Relations Contact President Director/Board Member Chief Operating Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member General Counsel Director/Board Member Sales & Marketing | |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Cardurion Pharmaceuticals LLC
 Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Director/Board Member | |
The Marine Biological Laboratory
 The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Kallyope, Inc.
 Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| INVIVYD, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
| University of Virginia | College/University | Undergraduate Degree Masters Business Admin | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Public Communications Contact | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| NEOGENOMICS, INC. | Medical/Nursing Services | Chief Executive Officer General Counsel | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| AC IMMUNE SA | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| Wesleyan University | College/University | Director/Board Member Undergraduate Degree | |
Skadden, Arps, Slate, Meagher & Flom LLP
 Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Skadden, Arps, Slate, Meagher & Flom LLP provides legal advisory services. Its practice areas include mergers and acquisitions, finance, litigation, corporate finance, insurance, tax, labor and employment, political law, private equity, corporate, antitrust, white collar crime, international, regulatory, and legislation. The company was founded by Marshall Skadden, John Slate, and Les Arps in 1948 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Graduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Director/Board Member | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
STJ Advisors LLP
 STJ Advisors LLP Investment ManagersFinance STJ Advisors LLP provides capital markets advisory services. The private company is based in London, UK and has subsidiaries in Hong Kong. The British company was founded in 2008 by John James Moore St. John. | Investment Managers | Corporate Officer/Principal | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 33 |
| Vereinigtes Königreich | 6 |
| Schweiz | 5 |
| Frankreich | 4 |
| Dänemark | 3 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 5 |
| Health Services | 3 |
Operativ
| Director/Board Member | 263 |
| Corporate Officer/Principal | 94 |
| Independent Dir/Board Member | 84 |
| Undergraduate Degree | 38 |
| Chairman | 36 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Terry McGuire | 51 |
| Amy Schulman | 45 |
| Jay Shepard | 30 |
| Catherine Moukheibir | 29 |
| Julie McHugh | 26 |
| Alexander Denner | 25 |
| Douglas Williams | 25 |
| Lawrence Olanoff | 22 |
| Andrew Dreyfus | 19 |
| Halley Gilbert | 17 |
| William I. Huyett | 14 |
| Gina Consylman | 14 |
| Sravan Emany | 14 |
| Michael Mendelsohn | 14 |
| Marsha Fanucci | 13 |
- Börse
- Insiders
- Greg Martini
- Unternehmensverbindungen